drugset / Trial / NCT01320878

Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension After Repair of Congenital Heart Disease

NCT01320878

Phase 2 Completed 64 enrolled Shanghai Jiao Tong University School of Medicine
RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this study was to assess the efficacy and appropriate dose of iloprost for inhalation in the treatment of postoperative pulmonary hypertension in children with congenital heart defects.

Timeline

Start
2007-10
Primary completion
2009-07
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iloprost Other / unclassified 30 unknown Other
Comparator Iloprost Other / unclassified 50 unknown Other